Covidien Sells One Peripheral Device While Touting Data On Another

Covidien announced it is selling its Stellarex drug-coated angioplasty balloon platform to Spectranetics for $30 million ahead of its merger with Medtronic, which makes the IN.PACT Admiral drug-coated balloon. But the company still plans to bring a significant peripheral vascular device portfolio along with it when it joins Medtronic.